Lucus Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Lucus Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$216K	Sell	15,183 -7,859	-34%	-$116K	0.37%	124
2017 Q4	$323K	Sell	23,042 -1,451	-6%	-$21.2K	0.47%	168
2017 Q3	$350K	Buy	+24,493	New	+$350K	0.49%	61
2016 Q1	–	Sell	-24,610	Closed	-$505K	–	375
2015 Q4	$505K	Sell	24,610 -555	-2%	-$10.6K	0.31%	28
2015 Q3	$430K	Sell	25,165 -2,240	-8%	-$40.9K	0.24%	202
2015 Q2	$511K	Buy	+27,405	New	+$508K	0.24%	80

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Lucus Advisors's VIVO Position: Q1 2018 in Review

Lucus Advisors reduced its Meridian Bioscience Inc (VIVO) stake by 34% in Q1 2018, selling an estimated $116K and leaving 15,183 shares worth $216K. The position accounts for 0.37% of the portfolio, ranked #124.

Lucus Advisors first reported a position in VIVO in Q2 2015 and has held it in 6 quarters since. The position peaked at $511K in Q2 2015. 186 funds tracked by Wall St. Rank hold VIVO as of Q1 2018.

Lucus Advisors held 15,183 shares of Meridian Bioscience Inc worth $216K as of Q1 2018.
Lucus Advisors sold 7,859 Meridian Bioscience Inc shares in Q1 2018, an estimated $116K.
Meridian Bioscience Inc made up 0.37% of Lucus Advisors's portfolio in Q1 2018, its #124 holding.
Lucus Advisors first reported a position in Meridian Bioscience Inc in Q2 2015 and has held it in 6 quarters since.
Lucus Advisors's Meridian Bioscience Inc position peaked at $511K in Q2 2015.
186 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2018.

Based on Lucus Advisors's 13F filing for Q1 2018, filed 15 May 2018.